BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 18235148)

  • 1. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC; Sethi S; Specks U
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic membranous nephropathy in an elderly patient with type 2 diabetes mellitus].
    Costero O; Díaz C; de Alvaro F; Torre A; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2001; 21(4):402-5. PubMed ID: 11816518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus.
    Ahmed MS; Hou SH; Battaglia MC; Picken MM; Leehey DJ
    Am J Kidney Dis; 2007 Dec; 50(6):1028-32. PubMed ID: 18037104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
    Stahl RA; Hoxha E; Helmchen U
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in primary glomerular disease in 2007].
    Ara J
    Nefrologia; 2008; 28 Suppl 5():85-9. PubMed ID: 18847426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP; Stirling CM; Geddes CC
    Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of membranous glomerulonephritis: analysis of data from the Italian Renal Biopsy Registry].
    Garozzo M; Puliatti D; Battaglia GG
    G Ital Nefrol; 2011; 28(4):425-30. PubMed ID: 21809312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membranous nephropathy].
    Passos EM; Legallicier B; Godin M
    Rev Prat; 2003 Nov; 53(18):2033-8. PubMed ID: 15008218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
    Muñoz Díaz AB; Aguilar P
    Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F; Chiodini P; De Nicola L; Minutolo R; Zamboli P; Gallo C; Conte G
    Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.